← back to search

Brett L. Ecker

Northwestern University · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Skin Protection and Aging, Cancer Genomics and Diagnostics, and Gallbladder and Bile Duct Disorders.
h-index
34
citations
4,346
works
267
NIH funding
primary concept
Medicine
email

Recent publications

Global cooperation and localized pancreatic cancer.
2026cited by 0position: contributordoi
Immunogenomic Characterization of Malignant Transformation in Intraductal Papillary Mucinous Neoplasms.
2026cited by 0position: contributordoi
Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy
Nature 2025cited by 3position: middledoi
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Cancer Cell 2024cited by 60position: middledoi
Operative trends for pancreatic and hepatic malignancies during the COVID-19 pandemic.
2024cited by 0position: contributordoi
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma.
2023cited by 19position: contributordoi
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Nature 2022cited by 175position: middledoi
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy.
PubMed 2022cited by 34position: middledoi
Registry-based randomized clinical trials in surgery: Working with ACS-NSQIP and the AHPBA to conduct pragmatic trials.
2022cited by 4position: contributordoi
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis
Surgery 2021cited by 24position: middledoi
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Cancer Discovery 2020cited by 150position: middledoi
The Fistula Risk Score Catalog
Annals of Surgery 2020cited by 48position: middledoi
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development
Surgery 2020cited by 41position: middledoi
Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma
European Journal of Surgical Oncology 2020cited by 31position: middledoi
Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma
JAMA Surgery 2019cited by 80position: firstdoi
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Clinical Cancer Research 2018cited by 360position: middledoi
Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
Cell 2018cited by 223position: middledoi
Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis
Cancer Discovery 2018cited by 145position: firstdoi
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database
Journal of the American College of Surgeons 2018cited by 72position: middledoi
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy
Annals of Surgery 2018cited by 68position: middledoi
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy
Annals of Surgery 2017cited by 212position: firstdoi
Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy
Annals of Surgery 2017cited by 164position: firstdoi
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies
Journal of Gastrointestinal Surgery 2017cited by 24position: firstdoi
Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios
Journal of Gastrointestinal Surgery 2016cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ashani T. Weeraratna · Johns Hopkins University5 papers (2018–2025)Xiaowei Xu · Wannan Medical College4 papers (2018–2025)Marie R. Webster · Thomas Jefferson University4 papers (2018–2025)Gretchen M. Alicea · Johns Hopkins University4 papers (2018–2025)Stephen M. Douglass · Johns Hopkins University4 papers (2018–2025)Mitchell E. Fane · The Wistar Institute4 papers (2018–2025)Hsin‐Yao Tang · The Wistar Institute3 papers (2020–2025)Vito W. Rebecca · Johns Hopkins University3 papers (2020–2025)Charles M. Vollmer · Penn Center for AIDS Research3 papers (2016–2018)Gloria E. Marino · Johns Hopkins Medicine3 papers (2018–2025) · 3 papers (2018–2025)Andrew V. Kossenkov · University of Pittsburgh3 papers (2020–2025)Meenhard Herlyn · The Wistar Institute3 papers (2020–2025)David W. Speicher · The Wistar Institute3 papers (2020–2025)Matthew T. McMillan · Memorial Sloan Kettering Cancer Center2 papers (2016–2018)Laura Hüser · Bloomberg (United States)2 papers (2022–2025)Wei Xu · Peking University2 papers (2022–2025)Julio A. Aguirre‐Ghiso · Tisch Cancer Institute2 papers (2022–2025)Daniel J. Zabransky · Convergence2 papers (2022–2025)Laura Maggino · Twitter (United States)2 papers (2018–2018)